APA (7th ed.) Citation
(2025). Anifrolumab in Refractory Dermatomyositis and Antisynthetase Syndrome. Case Reports in Rheumatology.
Chicago Style (17th ed.) Citation
"Anifrolumab in Refractory Dermatomyositis and Antisynthetase Syndrome." Case Reports in Rheumatology 2025.
MLA (9th ed.) Citation
"Anifrolumab in Refractory Dermatomyositis and Antisynthetase Syndrome." Case Reports in Rheumatology, 2025.
Warning: These citations may not always be 100% accurate.